Lipid- and polymer-based nanocomplexes in nucleic acid delivery as cancer vaccines.
2021
Cancer vaccines consist of nucleic acid derivatives such as plasmid DNA, small interfering RNA and mRNA, and can be customized according to the patient’s needs. Nanomedicines have proven to be exceptionally good as miniaturized drug carriers, and thus they offer great advantages for delivering cancer vaccines. This review provides an overview of the literature on cancer vaccines, from their inception to current developments in the field.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
104
References
4
Citations
NaN
KQI